AbbVie Inc. (ABBV)
AbbVie Inc. Revenue
| Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14.2B | $15.6B | $17.4B | $18.4B | $18.8B | $20.0B | $22.9B | $25.6B | $28.2B | $32.8B | $33.3B | $45.8B | $56.2B | $58.1B | $54.3B |
AbbVie Inc. (ABBV) Revenue comparison analysis
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Nov 2024, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Nov 2024, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Nov 2024.
investors
worldwide
FAQ
1) What is AbbVie Inc.'s Revenue?
As of today, AbbVie Inc.'s last 12-month Revenue is $55.5B, based on the financial report for Sep 30, 2024 (Q3 2024).
2) What is AbbVie Inc.'s Revenue growth rate?
Over the last year, AbbVie Inc.'s Revenue growth was 0.7%. The average annual Revenue growth rates for AbbVie Inc. have been 3.4% over the past three years, 11.1% over the past five years.
3) Is AbbVie Inc.'s Revenue growth rate Good?
Over the last year, AbbVie Inc.'s Revenue growth was 0.7%, which is higher than industry growth of 0.1%. It indicates that AbbVie Inc.'s Revenue growth is Good.